OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
ZD Ziff Davis
- 37.750
- +0.170+0.45%
Close Apr 1 16:00 ET
- 37.750
- 0.0000.00%
Post 16:40 ET
1.62BMarket Cap26.58P/E (TTM)
38.420High36.920Low517.93KVolume37.690Open37.580Pre Close19.59MTurnover1.23%Turnover Ratio26.58P/E (Static)42.92MShares60.62052wk High0.89P/B1.59BFloat Cap36.82052wk Low--Dividend TTM42.18MShs Float135.000Historical High--Div YieldTTM3.99%Amplitude0.159Historical Low37.832Avg Price1Lot Size
Ziff Davis Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.76%1.4B | 5.88%412.82M | 3.69%353.58M | -1.60%320.8M | 2.39%314.49M | -1.94%1.36B | -1.72%389.89M | -0.26%340.99M | -3.36%326.02M | -2.52%307.14M |
| Operating revenue | 2.76%1.4B | 5.88%412.82M | 3.69%353.58M | -1.60%320.8M | 2.39%314.49M | -1.94%1.36B | -1.72%389.89M | -0.26%340.99M | -3.36%326.02M | -2.52%307.14M |
| Cost of revenue | 7.90%200.32M | 28.26%47.42M | -4.11%53.24M | 10.90%52.59M | 2.92%47.07M | 0.60%185.65M | -7.19%36.97M | 5.56%55.53M | 3.08%47.42M | -0.80%45.73M |
| Gross profit | 1.95%1.2B | 3.54%365.4M | 5.21%300.34M | -3.73%268.21M | 2.30%267.42M | -2.33%1.18B | -1.11%352.91M | -1.32%285.46M | -4.38%278.6M | -2.81%261.41M |
| Operating expense | 1.37%1B | 5.40%286.88M | 1.01%244.37M | -0.02%239.64M | -1.51%231.56M | 0.90%988.92M | 3.34%272.19M | 3.89%241.93M | -2.35%239.7M | -1.39%235.1M |
| Selling and administrative expenses | 5.87%723.16M | 191.53%57.41M | 2.13%229.11M | 0.43%222.85M | -1.57%213.78M | 1.55%683.09M | 67.00%19.69M | 4.28%224.33M | -1.71%221.88M | -1.27%217.18M |
| -Selling and marketing expense | 6.63%519.69M | 19.03%150.51M | 1.88%127.42M | 4.03%124.77M | 0.93%117M | -0.70%487.37M | -2.55%126.45M | 4.68%125.06M | -3.10%119.93M | -1.56%115.92M |
| -General and administrative expense | 3.95%203.46M | 12.79%-93.1M | 2.44%101.7M | -3.80%98.08M | -4.42%96.78M | 7.62%195.73M | 9.51%-106.76M | 3.77%99.27M | -0.02%101.95M | -0.93%101.26M |
| Research and development costs | -2.16%67.37M | 12.99%17.55M | -13.31%15.26M | -5.74%16.8M | -0.78%17.77M | -7.06%68.86M | -14.71%15.53M | -0.78%17.6M | -9.65%17.82M | -2.78%17.91M |
| Depreciation amortization depletion | -10.57%211.92M | ---- | ---- | ---- | ---- | 1.53%236.97M | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | -10.57%211.92M | ---- | ---- | ---- | ---- | 1.53%236.97M | ---- | ---- | ---- | ---- |
| Operating profit | 4.99%198.92M | -2.72%78.52M | 28.57%55.97M | -26.55%28.57M | 36.28%35.86M | -16.28%189.46M | -13.63%80.72M | -22.82%43.53M | -15.24%38.9M | -13.90%26.32M |
| Net non-operating interest income expense | 30.17%-13.99M | -183.92%-6.39M | -42.85%-4.02M | 82.79%-1.8M | 60.51%-1.77M | 40.81%-20.03M | 58.49%-2.25M | 67.09%-2.82M | -9.55%-10.48M | 56.46%-4.48M |
| Non-operating interest expense | -30.17%13.99M | 183.92%6.39M | 42.85%4.02M | -82.79%1.8M | -60.51%1.77M | -40.81%20.03M | -58.49%2.25M | -67.09%2.82M | 9.55%10.48M | -56.46%4.48M |
| Other net income (expense) | 2.88%-91.74M | 200.70%2.44M | -32.31%-87.91M | 277.02%8.32M | 30.18%-14.59M | -54.05%-94.46M | -168.70%-2.42M | -694.07%-66.44M | 92.94%-4.7M | -306.28%-20.9M |
| Gain on sale of security | 72.80%-7.65M | --0 | ---- | 195.46%3.05M | 46.44%-10.71M | 47.78%-28.14M | -86.77%1.07M | -228.83%-6.02M | 95.77%-3.2M | -323.30%-19.99M |
| Special income (charges) | -56.65%-89.05M | --0 | -50.00%-85.27M | --0 | ---3.78M | -258.36%-56.85M | --0 | -229.43%-56.85M | --0 | --0 |
| -Less:Impairment of capital assets | 50.00%85.27M | --0 | 50.00%85.27M | ---- | ---- | 107.72%56.85M | --0 | 107.72%56.85M | ---- | ---- |
| -Gain on sale of business | ---3.78M | --0 | --0 | --0 | ---3.78M | --0 | --0 | --0 | --0 | --0 |
| Other non- operating income (expenses) | 152.47%4.97M | 169.94%2.44M | 26.27%-2.63M | 450.43%5.27M | 88.55%-104K | -212.22%-9.47M | 22.96%-3.49M | -184.66%-3.57M | -123.69%-1.5M | -137.85%-908K |
| Income before tax | 24.30%93.19M | -1.94%74.57M | -39.78%-35.96M | 47.95%35.08M | 1,977.00%19.5M | -42.83%74.97M | -16.94%76.05M | -165.17%-25.73M | 178.30%23.71M | -96.91%939K |
| Income tax | 71.36%41.37M | 5.00%13.61M | 135.03%12.54M | 8.19%6.99M | 1,436.20%8.23M | -58.34%24.14M | -47.58%12.96M | -70.52%5.34M | -35.72%6.46M | -112.13%-616K |
| Earnings from equity interest net of tax | 220.30%11.22M | 830.95%3.13M | -185.56%-77K | 1,638.74%8.82M | 92.98%-645K | -20.69%-9.33M | -85.68%336K | 102.82%90K | 90.61%-573K | -1,069.68%-9.18M |
| Net income | 51.91%63.05M | 1.05%64.09M | -56.85%-48.58M | 121.30%36.91M | 239.33%10.63M | -34.90%41.5M | -6.00%63.42M | -270.31%-30.97M | 135.92%16.68M | -131.08%-7.63M |
| Net income continuous Operations | 51.91%63.05M | 1.05%64.09M | -56.85%-48.58M | 121.30%36.91M | 239.33%10.63M | -36.60%41.5M | -8.32%63.42M | -270.31%-30.97M | 135.92%16.68M | -131.08%-7.63M |
| Net income discontinuous operations | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 51.91%63.05M | 1.05%64.09M | -56.85%-48.58M | 121.30%36.91M | 239.33%10.63M | -34.90%41.5M | -6.00%63.42M | -270.31%-30.97M | 135.92%16.68M | -131.08%-7.63M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | -90.00%2K | -90.00%2K | 0 | 2K | 0 |
| Net income attributable to common stockholders | 51.92%63.05M | 1.05%64.09M | -56.85%-48.58M | 121.32%36.91M | 239.33%10.63M | -34.89%41.5M | -5.98%63.42M | -270.35%-30.97M | 135.91%16.68M | -131.10%-7.63M |
| Basic earnings per share | 59.55%1.42 | 8.63%1.51 | -65.67%-1.11 | 125.00%0.81 | 243.75%0.23 | -34.56%0.89 | -3.47%1.39 | -271.79%-0.67 | 136.36%0.36 | -130.77%-0.16 |
| Diluted earnings per share | 59.55%1.42 | 10.85%1.43 | -65.67%-1.11 | 113.89%0.77 | 243.75%0.23 | -34.56%0.89 | -3.73%1.29 | -271.79%-0.67 | 136.36%0.36 | -131.37%-0.16 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings